Concepedia
Statistics
Publications
7
Citations
218
H-Index
Active since
2012
Affiliations
Kütahya Dumlupınar Üniversitesi(Current)
Bursa Uludağ Üni̇versi̇tesi̇
Kutahya Saglik Bilimleri Universitesi
Istanbul Medipol University
Emrah Okur is an author at Kütahya Dumlupınar Üniversitesi specializing in oncology, molecular oncology, and bortezomib therapy.
Publications per year
2012–2019
The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib
Azmi Yerlikaya, Emrah Okur, Engı̇n Ulukaya · Tumor Biology · 2012 · 61 citations
Medicine, Oncology, Pharmacology +16
Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
Şükrü Aydın Düzgün, Azmi Yerlikaya, Sezgin Zeren et al. · Cytotechnology · 2017 · 50 citations · Full text
Medicine, Oncology, Pharmacology +13
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line.
Azmi Yerlikaya, Emrah Okur, Semih Eker et al. · PubMed · 2013 · 31 citations
A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line
Azmi Yerlikaya, Emrah Okur, Ahmet Tarık Baykal et al. · Journal of Proteomics · 2014 · 25 citations
Life Sciences, Molecular Biology, Oncology +16
A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
Azmi Yerlikaya, Elif Erdoğan, Emrah Okur et al. · Oncology Letters · 2016 · 22 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 7